Shares Issued
As at 27 November 2020, the number of shares in issue was 433,636,255.
Significant Shareholders
As at 27 November 2020
| Shareholder | Number | Ordinary Shares % |
|---|---|---|
| Craig Auringer | 23,837,250 | 5.50 |
| Samantha Bauer | 17,082,201 | 3.94 |
Director Shareholdings
As at 27 November 2020
| Director | Number | Ordinary Shares % |
|---|---|---|
| Alexis Sandler | 75,090,685 | 17.32 |
| Dr Vladislav Sandler | 41,544,677 | 9.58 |
| Peter Redmond | 5,596,270 | 1.29 |
Shares Not In Public Hands
Insofar as it is aware, as at 27 November 2020, 45.51% of the Company’s securities were not in public hands.
UK City Code On Takeovers And Mergers
The Company is subject to the provisions of the City Code on Takeovers and Mergers.
Shareholder Circulars
Annual and Half Year Reports, together with historical general meeting notices, blank proxy voting forms, and other shareholder circulars, may be found here: Annual and Half Year Reports.
Most recent shareholder circular:
| 8 December 2020 | Notice of General Meeting to be held on 6 January 2021 |
Other Exchanges And Trading Platforms
Hemogenyx Pharmaceuticals plc has not applied or agreed to have any of it securities admitted or traded on any other exchanges or trading platforms.